iSERA Lifesciences Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹143.90.
iSERA Lifesciences has an upper circuit limit of ₹143.90 and a lower circuit limit of ₹136.75. The total value traded stands at ₹0.00, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1. iSERA Lifesciences also offers a dividend yield of 0%.
iSERA Lifesciences Share Price Chart
iSERA Lifesciences Share Key Metrics
Volume
0.00
Market Cap
353.88 CR
LTQ@LTP
0@143.90
ATP
0
Var Margin
100 %
Circuit Range
136.75-143.9
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
1
iSERA Lifesciences Resistance and Support
Pivot 143.9
Resistance
First Resistance
143.9
Second Resistance
143.9
Third Resistance
143.9
Support
First Support
143.9
Second Support
143.9
Third Support
143.9
iSERA Lifesciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
iSERA Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-20 | Preferential issue of shares |
| 2026-02-10 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-09 | Rights issue of Equity Shares |
| 2025-10-03 | Rights issue of Equity Shares |
| 2025-08-01 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-10 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| Rights Date | Ratio | |
|---|---|---|
| 2025-10-24 | 25:1 | View More |
iSERA Lifesciences News
iSERA Lifesciences Ltd - 534920 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
iSERA Lifesciences promoters acquired a significant number of equity shares through a preferential allotment on a share swap basis on October 1, 2026. Key allottees include Shubhangi Garad (27,55,000 shares) and Sumeet Garad (11,92,000 shares).
Oct 08 2026 18:38:44
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Archana Kakasaheb Lonkar acquired 4,95,000 shares of iSERA Lifesciences via a preferential allotment share swap. Following the transaction and the expansion of total equity capital, her holding in the company has been revised from 8.32% to 4.86%.
Oct 07 2026 10:38:05
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Dhairyasheel Vasantrao Yadav acquired 4,50,500 shares in iSERA Lifesciences via a preferential allotment (share swap) on October 1, 2026. Following the capital expansion, the promoter's overall percentage holding stands at 6.37%.
Oct 06 2026 17:51:09
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Promoter Sumeet Dhanraj Garad acquired 11.92 lakh shares in iSERA Lifesciences through a preferential allotment share swap. This acquisition increases his total holding in the company from 1.19% to 5.25%.
Oct 06 2026 17:13:57
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Pratap Dadasaheb Deshmukh and PACs acquired 86.13 lakh shares via preferential allotment (share swap) on October 1, 2026. The promoter group's overall relative holding decreased from 58.63% to 55.07% due to the expansion of the total share capital.
Oct 06 2026 16:27:51
iSERA Lifesciences Ltd - 534920 - Announcement under Regulation 30 (LODR)-Allotment
iSERA Lifesciences approved the preferential allotment of 1.61 crore equity shares at Rs.48.20 per share on a swap basis. The shares are allotted to the existing shareholders of iSERA Biological Limited.
Oct 01 2026 12:04:15
iSERA Lifesciences Ltd - 534920 - Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) (The "Company") Held On October 01, 2026.
iSERA Lifesciences board approved the allotment of 1.61 crore equity shares at Rs. 48.20 per share on a preferential basis. The allotment was executed via a share swap for acquiring iSERA Biological Limited, increasing the post-issue paid-up capital to 2.45 crore shares.
Oct 01 2026 12:01:35
iSERA Lifesciences Management
| Name | Position |
|---|---|
| Jayshree Suresh | Managing Director |
| Jitendra Prabhakar Nene | Executive Director |
iSERA Lifesciences Similar Stocks
CyberTech Systems And Software Ltd.
130.10
-1.65 (1.25%)
Dev Accelerator Ltd.
43.25
3.51 (8.83%)
XT Global Infotech Ltd.
26.19
-0.27 (1.02%)
Ace Software Exports Ltd.
200.35
5.20 (2.66%)
Digispice Technologies Ltd.
16.00
0.27 (1.72%)
Inspirisys Solutions Ltd.
82.69
-2.98 (3.48%)
Sattrix Information Security Ltd.
292.50
4.75 (1.65%)
iSERA Lifesciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ISERA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC